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During 2 successive rainy seasons, January 2008 
through May 2008 and November 2008 through March 
2009, Rift Valley fever virus (RVFV) caused outbreaks in 
Madagascar. Human and animal infections were conﬁ  rmed 
on the northern and southern coasts and in the central 
highlands. Analysis of partial sequences from RVFV strains 
showed that all were similar to the strains circulating in Ke-
nya during 2006–2007. A national cross-sectional serologic 
survey among slaughterhouse workers at high risk showed 
that RVFV circulation during the 2008 outbreaks included 
all of the Malagasy regions and that the virus has circulated 
in at least 92 of Madagascar’s 111 districts. To better pre-
dict and respond to RVF outbreaks in Madagascar, further 
epidemiologic studies are needed, such as RVFV complete 
genome analysis, ruminant movement mapping, and sur-
veillance implementation. 
R
ift Valley fever virus (RVFV) belongs to the family 
Bunyaviridae, genus Phlebovirus, and was ﬁ  rst iso-
lated in 1930 during an investigation of a large epizootic in 
Kenya. Virions are enveloped and contain 3 single-stranded 
RNA genome segments designated large (L), medium (M), 
and small (S) coding for the viral proteins. 
Rift Valley fever (RVF) is an arthropod-borne zoono-
sis; it affects ruminants and is characterized by high rates 
of abortion and death in young and adult animals. Eco-
nomic consequences of this disease can be devastating. In 
humans, symptoms are usually mild, but in severe cases 
hemorrhage, meningoencephalitis, retinopathy, and death 
can occur. RVFV has been detected across Africa, from 
Senegal to Madagascar and from Egypt to South Africa. In 
2000, RVFV reached the Arabian Peninsula (1).
Animals are typically infected before humans. RVFV 
is transmitted between ruminants primarily by bites of 
mosquitoes of numerous genera and species. Humans can 
also be infected by these vectors as well as by contact or in-
halation of aerosols generated when handling sick or dead 
infected animals or their fresh tissues. Treatment of human 
patients is based on signs and symptoms; a commercial 
vaccine is available for animals only. RVFV outbreaks are 
periodic and occur every 10–15 years. Between epidem-
ics, the virus is believed to be maintained through vertical 
transmission by mosquitoes of the genus Aedes. Outbreaks 
are closely linked to climate variations, especially wide-
spread increased rainfall, that favor the hatching of mosqui-
to eggs and the subsequent emergence of a large number of 
adult mosquitoes (2). Moderate or large outbreaks that have 
been documented in the Horn of Africa (1989, 1997–1998, 
2006–2007) were associated with widespread rainfall. For 
the purpose of predicting RVF outbreaks in this area, a 
model based on several satellite-derived observations has 
been proposed (3).
RVFV has also been detected in Madagascar. The 
ﬁ  rst isolate was obtained from mosquitoes caught during 
the March 1979 rainy season in a forest area in the Mora-
manga district (no. 514; online Appendix Figure, www.
cdc.gov/EID/content/16/6/963-appF.htm), 120 km east of 
Antananarivo (4). Then in March 1990, an RVF epizootic 
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occurred in Fenoarivo Atsinana (district 509) on the east 
coast, where an abnormally high incidence of abortions and 
disease in humans was reported (5,6). A year later, from 
February through April 1991, RVFV was responsible for 
abortions and deaths of cattle in the central highlands. Hu-
man cases were also conﬁ  rmed (7,8). After the outbreaks of 
RVF in 2006 and 2007 in the Horn of Africa (9), 17 years 
later, the virus was again detected in Madagascar during a 
major outbreak. We report some features of this outbreak 
and the results of preliminary molecular characterization 
of the circulating virus. We also performed a nationwide 




In 1996, in accordance with World Health Organiza-
tion resolution AFR/RC43/R7, the Integrated Diseases 
Surveillance and Response system was implemented by the 
Direction des Urgences et de la Lutte contre les Maladies 
(DULM) from the Malagasy Ministry of Health. Hemor-
rhagic fevers are among the reportable diseases. Each week, 
basic health centers and hospitals (district and regional) 
must notify DULM about cases or absence of cases. 
In addition, in 2007 the DULM set up, in collabora-
tion with the Institut Pasteur de Madagascar (IPM), a sen-
tinel surveillance system including 19 clinical sites (basic 
health centers). Each site reports daily to the central level 
(DULM and IPM) the number of patients, persons with fe-
ver, conﬁ  rmed malaria cases, suspected arboviral disease 
cases, and suspected inﬂ  uenza cases. Suspected arboviral 
disease cases were deﬁ  ned as cases in patients with axillary 
temperature >37.5°C and >2 of the following signs: head-
ache, myalgia, arthralgia, retro-orbital pain, and cutaneous 
rash or hemorrhagic signs. Of the 19 centers, 4 are also 
biological surveillance sites. Serum samples from patients 
with suspected arboviral disease are sent weekly in liquid 
nitrogen to the IPM.
During the outbreak, a suspected case of RVF was de-
ﬁ  ned as illness in a person with a hemorrhagic syndrome 
and history of fever or as encephalitis and a dengue-like 
syndrome after exposure to sick or dead ruminants or ex-
posure to ruminants in a village where sick or dead animals 
had been reported since detection of the ﬁ  rst cases.
Laboratory Diagnosis
Serologic Assays
RVFV immunoglobulin (Ig) M and IgG ELISAs were 
performed as described previously (10). After heat and 
detergent inactivation, serum samples were tested by anti-
RVFV–speciﬁ  c IgM and IgG ELISAs. The assays were 
completed by using inactivated RVFV-infected Vero E6 
cell antigens and uninfected Vero E6 cell antigens; 4 dilu-
tions of each serum (1:100, 1:400, 1:1,600, 1:6,400) were 
used. Titers and the cumulative sum of optical densities of 
each dilution (SUMOD) minus the background absorbance 
of uninfected control Vero E6 cells (adjusted SUMOD) 
were recorded. Results of the assays for serum samples 
were considered positive only if the adjusted SUMOD and 
titer were above preestablished conservative cutoff values, 
which were set for IgM ELISA (>0.75 and >400, respec-
tively) and IgG ELISA (>0.95 and >400, respectively). A 
probable RVFV infection was one in which no RVFV was 
detected but antibodies were detected. Infection was con-
sidered recent when IgM against RVFV was detected and 
past when only IgG against RVFV (no IgM against RVFV) 
was detected.
Virologic Assays
Virus isolation was performed on mosquito cell lines 
(AP61 and Vero E6) by using acute-phase serum samples 
(diluted 1:10), and virus identiﬁ  cation was performed by 
an indirect immunoﬂ  uorescence assay that used pools of 
mouse immune ascetic ﬂ  uids (11). These ﬂ  uids reacted 
against several arboviruses previously isolated from Mada-
gascar, including RVFV.
Molecular Assays
Liver or spleen specimens (50–100 mg) from dead 
animals with suspected RVF were homogenized at a dilu-
tion of 1:10 in culture medium containing 30% fetal bo-
vine serum. The supernatant was collected after centrifu-
gation. Viral RNA was extracted from the serum samples 
of patients and animals suspected of having infection by 
using the QIAamp Viral RNA Mini Kit (QIAGEN GmbH, 
Hilden, Germany) and from organ supernatants by using 
TRIzol LS reagent (Invitrogen, Carlsbad, CA, USA) ac-
cording to the manufacturers’ instructions.
The molecular detection of the virus was performed 
by using a nested reverse transcription–PCR (RT-PCR) de-
scribed by Sall et al. (12) or a real-time RT-PCR described 
by Weidmann et al. (13). The minimum level of detec-
tion was 25 transcript RNA copies per assay. A conﬁ  rmed 
RVFV infection was an infection in which RVFV was iso-
lated or RVFV RNA was detected.
Molecular Characterization
Parts of the S, M, and L segments of RVFV were am-
pliﬁ  ed and sequenced. S-ampliﬁ  ed product (portion of non-
structural protein) was obtained by using the nested RT-
PCR technique published by Sall et al. (12). M-ampliﬁ  ed 
product (portion of G2) was obtained by using RT-PCR 
primers M-F675 (5′-ACCATCATTGCAAAGGCTGA-3′) 
and M-R1645 (5′-GCCATGTGAACCCCTATGTC-3′) 
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and nested PCR primers MRV1a and MRV2g used 
by Sall et al. (14). L-ampliﬁ   ed product (portion of L) 
was obtained by using RT-PCR primers L-F4209 (5′-
GCGCATTGCAGAGAAAGTC) and L-R5113 (5′-CAA
CGTGATCACCATCTAGAAA-3′) and nested PCR prim-
ers L-F4273 (5′-TGTAAAGTCATGGCCTCAGC-3′) and 
L-R4878 (5′-CATCCGGGAGAAATTGTCA-3′). M-F675, 
M-R1645, L-F4209, L-R5113, L-F4273, and L-R4878 were 
designed to obtain M- and L-nested PCR products >600 bp; 
Primer3Plus software (15) was used according to 33 pub-
lished complete RVFV M or L sequences (16).
Ampliﬁ  cation products were sequenced on both strands 
by Cogenics (Meylan, France). Unveriﬁ  ed  sequences 
and chromatograms were compared and corrected when 
needed. Sequences from the same segment were compared 
when aligned, and a phylogenetic analysis was conducted 
by using MEGA version 4 software (17). The partial S, M, 
and L sequences obtained in this study are available from 
GenBank under accession nos. GQ443126–GQ443256.
Nationwide Serologic Survey
A nationwide cross-sectional serologic survey was con-
ducted among persons at risk for RVF. In all 111 districts 
of Madagascar (online Appendix Figure), persons were 
invited to participate in the survey if they had worked in 
slaughterhouses within the administrative center of the dis-
trict since 2007, had been exposed to fresh meat or blood of 
ruminants, and had been residents of the district when they 
started this work. The study was approved by the Malagasy 
National Ethical Committee. From those who gave written 
informed consent, 5 mL of blood was collected into red-top 
tubes. Samples; informed consent forms; and data sheets 
recording age, sex, location, date of sampling, and criteria 
of sampling were sent to the IPM, where RVFV IgG and 
IgM ELISAs were performed.
Results
Outbreaks 
The ﬁ  rst RVF case of 2008 was detected during rou-
tine activity of the biological surveillance sentinel center 
in Tolagnaro city (district no. 614) in southern Madagascar 
(Figure 1; online Appendix Figure). The virus was isolated 
on AP61 and Vero E6 cells from an acute-phase serum 
sample collected on January 30, 2008, from a pregnant 
woman who had had a dengue-like syndrome for 2 days. 
Retrospective investigation showed that each day she had 
collected fresh meat from a local slaughterhouse to make 
and sell meat kebabs. On February 5, 2008, the DULM 
received an alert through the Integrated Diseases Surveil-
lance and Response system. Cases of hemorrhagic fever 
and dengue-like fever, associated with deaths of farmers 
and with abnormal mortality rates for zebus, were reported 
from the Anjozorobe district (no. 107), 80 km north of An-
tananarivo. IgM against RVFV was detected in 16 of 23 
persons sampled on February 9, 2008. These patients had 
been ill 1–3 weeks earlier. Retrospective investigation sug-
gested that the virus had been circulating among livestock 
since December 2007.
Consequently, the DULM encouraged notiﬁ  cation and 
sampling of RVF suspected cases by the basic health cen-
ters and district and regional hospitals. Overall, from Janu-
ary 28 through June 15, 2008, when the active surveillance 
was stopped, 476 suspected cases (19 of which were fatal) 
from 15 districts, mostly from the central highlands, were 
reported to the DULM. 
Serum samples were received at IPM from 134 per-
sons with suspected cases who lived in 16 districts: 36 
cases were conﬁ  rmed, and 31 were considered probable. 
Laboratory analysis results were negative for the other 67. 
Most of the persons with probable and conﬁ  rmed cases had 
occupational risk; 54 were farmers and 5 were butchers. 
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Figure 1. Distribution of Rift Valley fever in the 111 administrative 
districts in Madagascar, 2008 and 2009. Districts with laboratory-
diagnosed conﬁ  rmed or probable cases in humans and/or animals 
are indicated by yellow (2008), orange (2009), or red (both years). 
In districts without conﬁ  rmed or probable cases, antibody data for 
Rift Valley fever virus immunoglobulin (Ig) levels in serum samples 
from at-risk professionals are indicated by green (IgM positive only), 
blue (IgG positive, IgM negative), or violet (IgG and IgM negative). 
No samples were received from districts shown in white.RESEARCH
Additionally, serum, organs, or fetuses were received from 
119 animals sampled by the Direction des Services Vété-
rinaires in 19 districts. Of the 119, cases were conﬁ  rmed 
for 15, considered probable for 7, and were negative for 
the other 97. Overall, RVFV conﬁ  rmed and probable cases 
were identiﬁ  ed in 19 districts (Figure 1). The last laborato-
ry-conﬁ  rmed case consisted of a fatal hemorrhagic disease 
that began on May 23, 2008, in a person from the Ampara-
faravola district (no. 504), near Lake Aloatra, 180 km north 
of Antananarivo.
Six months later, during the rainy season (October 
2008–May 2009), an alert was launched by the Direction 
des Services Vétérinaires when abnormally high death rates 
among cattle were reported from Fianarantosoa-I (no. 301) 
and Fianarantsoa-II (no. 302) districts (located in the cen-
tral highlands). Livers from 3 cows sampled on November 
28, 2008, and sent to IPM were infected with RVFV. Sus-
pected human RVF cases from this area were conﬁ  rmed. 
Overall, from December 1, 2008, through May 15, 2009, 
236 suspected cases (including 7 deaths) in humans, were 
reported to the DULM: 1 from Antananarivo (no. 101) 
and the rest from 4 neighboring districts: 74 cases from 
Fianarantsoa-I (no. 301), 152 from Fianarantsoa-II (no. 
302), 4 from Ambohimahasoa (no. 305), and 5 from Am-
balavao (no. 303). Of the 47 suspected cases sampled, 10 
were conﬁ  rmed and 9 were probable. Laboratory analysis 
results were negative for the other 28 cases. More than half 
of the 19 persons with conﬁ  rmed and probable cases were 
at high risk: 8 were farmers, 1 a butcher, 1 a veterinarian, 
and 1 (from Antananarivo) a cattle trader who transported 
animals from the south through the infected area to An-
tananarivo. Additionally, conﬁ  rmed or probable infection 
was detected in serum samples or livers from 24 ruminants 
among 88 sampled in Fianarantsoa-I and Fianarantsoa-II 
districts during the period. The last laboratory-conﬁ  rmed 
RVFV case was in a person who had hemorrhagic mani-
festations and lived in the Ambalavao district (no. 303); 
disease onset was March 13, 2009.
Genetic Analysis
Veriﬁ  ed partial S sequences encompassing 627 nt (po-
sitions 49–675 of the coding domain) were obtained from 
46 of the 51 RVFV-positive samples collected during the 
January–May 2008 outbreak. These 46 samples originated 
from 14 of the 17 districts where the virus was detected, in-
cluding the 3 main areas concerned (northern coast, south-
ern coast, and central highlands) (Figure 1; Table). Of these 
46 samples, 34 were collected from humans, 10 from cattle, 
1 from a sheep, and 1 from a goat (Table). The maximum 
nucleotide percent identity difference between the 46 se-
quences was low (0.96%; 6/627). Of 11 haplotypes of se-
quences detected, 1 included 35 identical sequences from 
strains originating from 5 districts (central highlands). At 
the protein level, the maximum percent identity difference 
was 1.4% (3/209): 7 haplotypes of sequences were detected 
(data not shown). The virus sequences of cattle strains were 
identical to those of human strains in the 2 districts where 
RVFV strains had been obtained from cattle and humans. 
Phylogenetic analysis, using the neighbor-joining method 
with the Kimura 2-parameter model, was undertaken for 
the 11 Madagascar sequences representative of all the di-
versity, the corresponding part of the 33 complete S se-
quences described by Bird et al. (16), and the 6 sequences 
representative of the lineages Kenya-1, -1a and -2 recently 
described during the 2006–2007 Kenya outbreak (18). Al-
though the bootstrap values did not support an unambigu-
ous phylogenetic classiﬁ  cation, the analysis showed that the 
Madagascar sequences were close to the Kenya sequences 
obtained from strains circulating in 2006–2007, especially 
to Kenya-1 and -1a lineages.
Partial M sequences (nt positions 781–1536 of the 
coding domain) and partial L sequences (nt positions 
1276–1839 of the coding domain) were available, respec-
tively, from 39 and 42 of the 46 strains from which we 
obtained the S sequence. Phylogenetic analysis performed 
as described above, and including the M or L sequences 
of the strains used for the S analysis, conﬁ  rmed that these 
sequences were closer to sequences obtained from Kenya 
strains circulating in 2006–2007 (data not shown).
Analysis of sequences from strains detected in during 
the second outbreak November and December 2008 was 
limited to 4 strains (6510–08, 6546–08, 6547–08, 6660–
08) and to the S segment (627 nt). All were close or identi-
cal to the Madagascar sequences detected during the ﬁ  rst 
outbreak and clustered within the Kenya-1 and -1a lineages 
(Figure 2).
Cross-Sectional Serologic Survey 
Conﬁ  rmed and probable cases were detected in the 
central highlands and in 2 nonadjoining and well-separated 
areas, the southern and northern coasts of the island (Fig-
ure 1). Geographic distribution of RVFV recent circulation 
was hypothesized to be larger. To conﬁ  rm this hypothesis, 
a nationwide serologic survey was organized. Serum was 
collected from September 27, 2008, through May 27, 2009, 
from 1,995 volunteers, who were at high risk for RVFV 
infection, from 106 of the 111 Malagasy districts. Probable 
recent RVFV infection was detected for 214 participants, 
probable past RVFV infection was detected for 219 par-
ticipants, and recent or past RVFV infection was ruled out 
for the rest (online Appendix Table, www.cdc.gov/EID/
content/16/6/963-appT.htm). Overall (considering the lo-
cation of the persons with conﬁ  rmed and probable cases), 
recent circulation of RVFV was detected in 70 districts and 
recent or past infection in 92 districts, which indicated wide 
circulation of RVFV in Madagascar (Figure 1).
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Discussion
Since the ﬁ  rst ﬁ  eld and laboratory investigations con-
ducted by IPM in the 1970s, 15 arboviruses have been iso-
lated in Madagascar, 10 of which are known to be patho-
genic for humans and 3 of which (dengue virus type 1, 
chikungunya virus, and RVFV) have been responsible for 
large outbreaks (4–8;19–22). The RVF outbreak in 2008–
2009 is the largest detected in the country, although during 
this outbreak the reporting and sampling for suspected cas-
es in humans and animals were not optimal. RVF is a rural 
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Table. Features of 46 sequenced Rift Valley fever viruses, Madagascar, 2008–2009  
Code   Species Sample type  Sampling date  District of sampling 
Coding sequences 
Small Medium Large 
212-08  Human  Serum  2008 Jan 30  Tolagnaro  Yes  Yes  Yes 
406-08  Bovine Fetal liver  2008 Feb 20  Miarinarivo Yes  Yes  Yes 
413-08  Bovine Fetal liver  2008 Feb 20  Antsirabe II  Yes  Yes  Yes 
427-08 Human  Serum  2008  Feb  22  Anjozorobe  Yes  Yes Yes 
428-08 Human  Serum  2008  Feb  15  Anjozorobe  Yes  Yes Yes 
435-08 Bovine Serum  2008  Feb  22  Anjozorobe  Yes  No Yes 
437-08 Bovine Serum  2008  Feb  22  Anjozorobe  Yes  No No
448-08 Human  Serum  2008  Feb  26  Anjozorobe  Yes  Yes Yes 
449-08 Human  Serum  2008  Feb  26  Anjozorobe  Yes  No Yes 
619-08  Human  Serum  2008 Mar 9  Ankazobe Yes  Yes  Yes 
682-08  Human  Serum  2008 Mar 12  Ambatondrazaka  Yes  Yes  Yes 
683-08  Human  Serum  2008 Mar 12  Ambatondrazaka  Yes  Yes  Yes 
684-08  Human  Serum  2008 Mar 12  Ambatondrazaka  Yes  Yes  Yes 
693-08  Human  Serum  2008 Mar 11  Amparafaravola  Yes  Yes  Yes 
776-08  Human  Serum  2008 Mar 14  Ambatondrazaka  Yes  Yes  Yes 
779-08  Human  Serum  2008 Mar 16  Amparafaravola  Yes  No Yes 
845-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
846-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes Yes 
847-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
848-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
849-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
850-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  No
851-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
852-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
853-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
854-08  Human  Serum  2008 Mar 23  Manjakandriana  Yes  Yes  Yes 
855-08  Bovine Serum  2008 Mar 24  Manjakandriana  Yes  Yes  Yes 
856-08  Bovine Serum  2008 Mar 24  Manjakandriana  Yes  No Yes 
857-08  Bovine Serum  2008 Mar 24  Manjakandriana  Yes  No No
859-08  Bovine Serum  2008 Mar 24  Manjakandriana  Yes  No Yes 
863-09  Human  Serum  2008 Mar 25  Antananarivo  Yes  Yes  Yes 
878-09  Human  Serum  2008 Mar 26  Amparafaravola  Yes  Yes  Yes 
879-08  Human  Serum  2008 Mar 26  Manjakandriana  Yes  Yes  Yes 
889-08  Human  Serum  2008 Mar 26  Manjakandriana  Yes  Yes  No
892-09  Human  Serum  2008 Mar 26  Manjakandriana Yes  Yes Yes 
895-09  Human  Serum  2008 Mar 26  Manjakandriana  Yes  Yes  Yes 
897-08  Human  Serum  2008 Mar 26  Manjakandriana  Yes  Yes  Yes 
1464-08  Human  Serum  2008 Mar 28  Tolagnaro  Yes  Yes  Yes 
1585-08  Caprine  Serum  2008 Apr 13  Antsiranana I  Yes  Yes  Yes 
1586-08  Human  Serum  2008 Apr 15  Antavy Atsimo  Yes  Yes  Yes 
1627-08  Bovine Serum  2008 Apr 18  Ambalavao Yes  Yes  Yes 
1695-08  Ovine Serum  2008 Apr 20  Antsiranana II  Yes  Yes  Yes 
1730-08  Bovine Spleen 2008 Apr 25  Fianarantsoa I  Yes  Yes  Yes 
2032-08  Human  Serum  2008 May 25  Amparafaravola  Yes  Yes  Yes 
2033-08  Human  Serum  2008 Apr 29  Amparafaravola  Yes  Yes  Yes 
2034-08  Human  Serum  2008 Apr 23  Amparafaravola  Yes  Yes  Yes 
6510-08  Bovine Liver 2008 Dec 1  Fianarantsoa I  Yes  Not done  Not done 
6546-08  Bovine Liver 2008 Nov 28  Fianarantsoa I  Yes  Not done  Not done 
6547-08  Bovine Liver 2008 Nov 29  Fianarantsoa II  Yes  Not done  Not done 
6660-08  Human  Serum  2008 Dec 12  Fianarantsoa I  Yes  Not done  Not done RESEARCH
disease occurring mainly during the rainy season. Transfer 
of information from the central administration to the health 
centers and back was challenging during this period in this 
low-income country. This lack of recorded information 
prevented us from describing the outbreak in more detail 
and estimating the extent of human disease. However, the 
extent of the disease could be established through a retro-
spective study in the outbreak area, comparing the crude 
death rate observed during the outbreak period with an ex-
pected death rate computed from data for previous years. 
The effect on livestock is even more difﬁ  cult to quantify 
because of the lack of animal population data and the lim-
ited number of specimens submitted for diagnosis.
The addition of the Madagascar RVFV 2008 strains 
to the Kenya-1 2006–2007 lineage raises the question of 
this lineage’s introduction from Kenya. We detected IgG 
against RVF in serum from 18 of 24 goats sampled by 
the end of June 2008 in Toliara II district (no. 602) on the 
southeast coast where abortions were reported in early 2007 
(J.-M.R., unpub. data). RVFV was probably circulating in 
this area while it was circulating in Kenya, and perhaps it 
was introduced from Kenya at that time. Ofﬁ  cial records 
document exportation (but no importation) of ruminants 
from Madagascar to the Comoros archipelago; subsequent 
exportation to the African continent is possible (L.T.R., 
pers. comm.). However, illegal importation cannot be ex-
cluded. The question of introduction remains unanswered. 
More complete phylogenetic studies, and full sequences of 
Madagascar 2008 isolates, are needed to detect the circu-
lation of >1 lineages during the 2008 outbreak and to get 
a better understanding of the movements and evolution of 
Madagascar and Kenya isolates.
The nationwide cross-sectional serosurvey supple-
mented the information obtained during the outbreak. The 
serologic observations suggest that the virus has probably 
circulated in the past in most districts and more recently, 
in 2008–2009, at least in all regions of the country. The 
sample collection from persons at risk started 3 months 
and ended 12 months after the detection of the last case of 
the 2008 outbreak. Despite not having data on duration of 
IgM against RVFV in humans, we suspect that IgM may 
have already disappeared in some of the serum samples 
tested and that the area of recent RVFV circulation is in-
deed larger than the one we studied. The lack of evidence 
of virus circulation in some adjoining districts from arid 
southern Madagascar may be also explained by our small 
sample size from some of them (online Appendix Table). 
However, the serologic investigation conducted among 
cattle sampled after the 2008 RVF outbreak indicated that 
the virus has circulated in the following districts: Midongy-
Atsimo (no. 318), Vangaindrano (no. 320), Ampanihy (no. 
605), Sakaraha (no. 620), Betioky (no. 612), and Toliara-I. 
(no. 601) (Elisabeth Jeanmaire, unpub. data) and reduced 
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Figure 2. Phylogenetic tree based on the entire small sequences 
from 33 Rift Valley fever virus strains described by Bird et al. 
(16), from 6 sequences representative of the Kenya 1, 1a, and 2 
lineages described by Bird et al. (18), and from 1 Madagascar strain 
circulating in 1991 and 12 Madagascar strains circulating in 2008. 
Boostrap percentages (from 1,000 resamplings) are indicated at 
each node. ¡ indicates sequences from the 2006–2007 Kenya-1 
lineage,  z indicates sequences from the 2006–2007 Kenya-1a 
lineage,  S indicates sequences from the 2006–2007 Kenya 2 
lineage, and  indicates the 2008 Madagascar sequences. Scale 
bar indicates nucleotide substitutions per site.Rift Valley Fever, Madagascar
the area of contiguous districts where the virus circulation 
was not detected to the following 6 districts: Iakora (no. 
311), Befotaka (no. 307), Amboasary-Atsimo (no. 603), 
Ambovombe-Androy (no. 604), Tsihombe (no. 621), and 
Bekily (no. 607).
Recent circulation of RVFV in the country was ex-
tensive. The detection of the same haplotype from serum 
sampled at the same period, from the 2 ﬁ  rst reported out-
break places 500 km apart may be explained by the large-
scale movement of cattle within the country. Observed 
movements of cattle from rural areas to provincial capi-
tals and between provincial capitals and Antananarivo, 
could explain the rapid spread of the virus. However, we 
do not know where the outbreak started; thus, reemergence 
of RVFV from different places cannot be ruled out. We 
found the results of some unpublished studies reporting the 
movement of ruminants in some areas, but a comprehen-
sive study of these movements is needed for a better under-
standing of the epidemiology of the disease and to organize 
its surveillance and control.
The geographic distribution of RVF encompasses 
all 4 ecozones of Madagascar (www.nationalgeographic.
com/wildworld/terrestrial.html). This ﬁ  nding suggests that 
mosquito transmission may occur in all of them. Extensive 
entomologic studies conducted out in the 1980s in Mada-
gascar have shown that some species described as vectors 
on the African continent were present in some or all 4 eco-
zones (19). This ﬁ  nding implies that cycles of transmission 
involving different species may occur in Madagascar. Until 
now, little information on RVFV vectors in Madagascar 
has been available (19). Thousands of mosquitoes were 
collected in the highlands during the 2008–2009 outbreaks. 
The results of the virus detection are still pending and will 
contribute to the knowledge of the RVFV vectors in Mada-
gascar.
The model used to predict at risk RVF situation has 
been efﬁ  cient in the Horn of Africa (3,23). When this mod-
el was applied to Madagascar, the area where probable and 
conﬁ  rmed cases were reported was not predicted to be at 
risk (24), suggesting that the model needs to be adjusted for 
Madagascar. This last point and the questions raised above 
underline the need for research studies and surveillance on 
RVF in Madagascar to better predict, declare, and respond 
to RVF outbreaks. 
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